Clinical Trial

A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The primary purpose of this study is to determine the metabolism and excretion of \[14C\]E2086 in healthy male participants.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-15.
Status change: Not Yet Recruiting → Recruiting 2026-03-04
Trial Details
NCT Number NCT07308236
Lead Sponsor Eisai Inc.
Conditions Healthy Volunteers
Enrollment 10 participants
Start Date 2025-12-31
Primary Completion 2026-02-23 (estimated)
Study Completion 2026-02-23 (estimated)
Updated on ClinicalTrials.gov 2026-03-05